Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram.
Grégoire M, Dailly E, Le Turnier P, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme YM, Hoff J, Lemaitre F, Verdier MC, Deslandes G, Bellouard R, Sébille V, Chiffoleau A, Boutoille D, Navas D, Asseray N. Grégoire M, et al. Among authors: sebille v. Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00634-19. doi: 10.1128/AAC.00634-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31235630 Free PMC article. Clinical Trial.
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study.
Le Turnier P, Navas D, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme YM, Hoff J, Chiffoleau A, Dary M, Leclair-Visonneau L, Grégoire M, Pere M, Boutoille D, Sébille V, Dailly E, Asseray N; High-Dose Ceftriaxone CNS Infections Study Group. Le Turnier P, et al. Among authors: sebille v. J Antimicrob Chemother. 2019 Apr 1;74(4):1078-1085. doi: 10.1093/jac/dky553. J Antimicrob Chemother. 2019. PMID: 30698733 Clinical Trial.
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.
Michelet C, Ruffault A, Sébille V, Arvieux C, Jaccard P, Raffi F, Bazin C, Chapplain JM, Chauvin JP, Dohin E, Cartier F, Bellissant E. Michelet C, et al. Among authors: sebille v. Antimicrob Agents Chemother. 2001 Dec;45(12):3393-402. doi: 10.1128/AAC.45.12.3393-3402.2001. Antimicrob Agents Chemother. 2001. PMID: 11709314 Free PMC article. Clinical Trial.
Etomidate increases susceptibility to pneumonia in trauma patients.
Asehnoune K, Mahe PJ, Seguin P, Jaber S, Jung B, Guitton C, Chatel-Josse N, Subileau A, Tellier AC, Masson F, Renard B, Malledant Y, Lejus C, Volteau C, Sébille V, Roquilly A. Asehnoune K, et al. Among authors: sebille v. Intensive Care Med. 2012 Oct;38(10):1673-82. doi: 10.1007/s00134-012-2619-8. Epub 2012 Jul 10. Intensive Care Med. 2012. PMID: 22777514 Clinical Trial.
Predictive factors of survival after thalidomide therapy in advanced multiple myeloma: long-term follow-up of a prospective multicenter nonrandomized phase II study in 120 patients.
Decaux O, Renault A, Sébille V, Moreau P, Attal M, Voillat L, Pegourie B, Tiab M, Facon T, Zerbib R, Grosbois B, Bellissant E; Intergroupe Francophone du Myélome. Decaux O, et al. Among authors: sebille v. Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):418-22. doi: 10.1016/j.clml.2012.06.003. Epub 2012 Sep 29. Clin Lymphoma Myeloma Leuk. 2012. PMID: 23025991 Clinical Trial.
Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients.
Camus C, Sebille V, Legras A, Garo B, Renault A, Le Corre P, Donnio PY, Gacouin A, Perrotin D, Le Tulzo Y, Bellissant E. Camus C, et al. Among authors: sebille v. Infection. 2014 Jun;42(3):493-502. doi: 10.1007/s15010-013-0581-1. Epub 2014 Jan 25. Infection. 2014. PMID: 24464791 Free article. Clinical Trial.
Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury.
Roquilly A, Feuillet F, Seguin P, Lasocki S, Cinotti R, Launey Y, Thioliere L, Le Floch R, Mahe PJ, Nesseler N, Cazaubiel T, Rozec B, Lepelletier D, Sebille V, Malledant Y, Asehnoune K; ATLANREA group. Roquilly A, et al. Among authors: sebille v. Eur Respir J. 2016 Apr;47(4):1219-28. doi: 10.1183/13993003.01314-2015. Epub 2016 Jan 7. Eur Respir J. 2016. PMID: 26743488 Free article.
Extubation Success Prediction in a Multicentric Cohort of Patients with Severe Brain Injury.
Asehnoune K, Seguin P, Lasocki S, Roquilly A, Delater A, Gros A, Denou F, Mahé PJ, Nesseler N, Demeure-Dit-Latte D, Launey Y, Lakhal K, Rozec B, Mallédant Y, Sébille V, Jaber S, Le Thuaut A, Feuillet F, Cinotti R; ATLANREA group. Asehnoune K, et al. Among authors: sebille v. Anesthesiology. 2017 Aug;127(2):338-346. doi: 10.1097/ALN.0000000000001725. Anesthesiology. 2017. PMID: 28640020 Free article.
148 results